CUSIP N62509109ORDINARY SHARESQ4 2025
36 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 16.94M | $594.39M |
| 2 | Capital World Investors | 9.98M | $350.24M |
| 3 | Ra Capital Management, L.P. | 9.55M | $335.02M |
| 4 | Fcpm III Services B.V. | 9.20M | $322.70M |
| 5 | Bain Capital Life Sciences Investors, LLC | 7.31M | $256.31M |
| 6 | Fmr LLC | 6.41M | $224.97M |
| 7 | Wellington Management Group LLP | 5.03M | $176.56M |
| 8 | Viking Global Investors LP | 4.20M | $147.46M |
| 4 | Nov 13, 2025 | Capital World Investors | 13G/A | 8.7% | 9.82M | SEC |
| 5 | Nov 7, 2025 | Bcls Fund III Investments, LP | 13D/A | 10.0% | — | SEC |
| 6 | Nov 4, 2025 | Frazier Life Sciences X, L.P. | 13D/A | 7.7% | — | SEC |
| 7 | Sep 30, 2025 | Forbion Capital Fund IV Cooperatief U.A. | 13D/A | 8.3% | — | SEC |
| 8 | Aug 20, 2025 | Frazier Life Sciences X, L.P. | 13D/A | 6.5% | — | SEC |
| 9 | Aug 13, 2025 | Capital World Investors | 13G/A | 7.5% | 8.39M | SEC |
| 10 | Aug 12, 2025 | Forbion Capital Fund IV Cooperatief U.A. | 13D/A | 9.4% | — | SEC |
See the full Schedule 13D/13G history for Newamsterdam Pharma Company.
Unlock full history| 9 |
| Deerfield Management Company, L.P. |
| 4.16M |
| $146.10M |
| 10 | Jennison Associates LLC | 3.49M | $122.40M |